Literature DB >> 15674370

Prevalence and significance of mutations in the familial Mediterranean fever gene in patients with Crohn's disease.

A Karban1, E Dagan, R Eliakim, A Herman, S Nesher, B Weiss, D Berkowitz, R Shamir, R Gershoni-Baruch.   

Abstract

The concurrence of Crohn's disease (CD) and familial Mediterranean fever was repeatedly reported. In this study we determined the distribution and contribution of MEFV gene mutations to CD susceptibility and clinical heterogeneity. An Israeli cohort of 209 CD patients (120 men and 89 women) was investigated for mutations in the MEFV gene. A detailed chart review, interview and physical examination were used to determine sociodemographic and clinical characteristics. MEFV and NOD2/CARD15 genotypes were analyzed in all patients and a genotype-phenotype correlation analysis was undertaken. The results of this study do not implicate MEFV mutations as major modifiers in CD. However, the E148Q MEFV variant was associated with susceptibility to perianal disease. More specifically, 19% (9/47) of CD patients with perianal disease carried the E148Q mutation compared to 6.7% (11/162) of CD patients without perianal involvement (OR 3.26, 95% CI 1.2-8.8, P=0.02). Although, for all mutations taken together, the prevalence of MEFV gene mutations among CD patients and controls was similar, the hypothesis that E148Q mutation modulates the phenotypic expression of CD is corroborated by the results of this study and needs to be further evaluated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15674370     DOI: 10.1038/sj.gene.6364156

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  10 in total

Review 1.  Genetics of inflammatory bowel disease: current status and future directions.

Authors:  Thomas D Walters; Mark S Silverberg
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

2.  Intrafamilial segregation analysis of the p.E148Q MEFV allele in familial Mediterranean fever.

Authors:  D O Tchernitchko; M Gérard-Blanluet; M Legendre; C Cazeneuve; G Grateau; S Amselem
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

3.  MEFV gene mutations and its impact on the clinical course in ulcerative colitis patients.

Authors:  Beytullah Yıldırım; Candan Tuncer; Derya Kan; Bilge Tunc; Mehmet Derya Demirag; E Ferda Percın; Seminur Haznedaroglu; Hakan Alagozlu
Journal:  Rheumatol Int       Date:  2010-03-12       Impact factor: 2.631

4.  Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect?

Authors:  Stavros Giaglis; Konstantinos Mimidis; Vassilios Papadopoulos; Konstantinos Thomopoulos; Prodromos Sidiropoulos; Stavros Rafail; Vassiliki Nikolopoulou; Eleni Fragouli; Georgios Kartalis; Athanasios Tzioufas; Dimitrios Boumpas; Konstantinos Ritis
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

5.  The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study.

Authors:  Muhammet Cinar; Ayhan Dinc; Ismail Simsek; Hakan Erdem; Bayram Koc; Salih Pay; Yusuf Tunca; Selim Kilic; Davud Gul
Journal:  Rheumatol Int       Date:  2008-07-03       Impact factor: 2.631

6.  An infant with severe refractory Crohn's disease and homozygous MEFV mutation who dramatically responded to colchicine.

Authors:  Zarife Kuloğlu; Aydan Kansu; Gonca Ustündağ; Z Birsin Özçakar; Arzu Ensari; Mesiha Ekim
Journal:  Rheumatol Int       Date:  2010-01-05       Impact factor: 2.631

7.  The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy.

Authors:  Sinan Sari; Odul Egritas; Buket Dalgic
Journal:  Eur J Pediatr       Date:  2007-05-23       Impact factor: 3.183

8.  Evaluation of the Clinical Effects and Frequency of MEFV Gene Mutation in Patients with Inflammatory Bowel Disease.

Authors:  S Sahin; D Gulec; S Günay; C Cekic
Journal:  Gastroenterol Res Pract       Date:  2021-11-15       Impact factor: 2.260

Review 9.  Tripartite motif family proteins in inflammatory bowel disease: Mechanisms and potential for interventions.

Authors:  Rirong Chen; Yizhe Tie; Jinyu Lu; Li Li; Zhirong Zeng; Minhu Chen; Shenghong Zhang
Journal:  Cell Prolif       Date:  2022-04-04       Impact factor: 8.755

10.  Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis.

Authors:  Alexandra-Chloé Villani; Mathieu Lemire; Edouard Louis; Mark S Silverberg; Catherine Collette; Geneviève Fortin; Elaine R Nimmo; Yannick Renaud; Sébastien Brunet; Cécile Libioulle; Jacques Belaiche; Alain Bitton; Daniel Gaudet; Albert Cohen; Diane Langelier; John D Rioux; Ian D R Arnott; Gary E Wild; Paul Rutgeerts; Jack Satsangi; Séverine Vermeire; Thomas J Hudson; Denis Franchimont
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.